Teleflex Total Assets 2010-2022 | TFX

Teleflex total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Teleflex total assets for the quarter ending September 30, 2022 were $6.758B, a 4% decline year-over-year.
  • Teleflex total assets for 2021 were $6.872B, a 3.93% decline from 2020.
  • Teleflex total assets for 2020 were $7.153B, a 13.36% increase from 2019.
  • Teleflex total assets for 2019 were $6.31B, a 0.51% increase from 2018.
Teleflex Annual Total Assets
(Millions of US $)
2021 $6,872
2020 $7,153
2019 $6,310
2018 $6,278
2017 $6,181
2016 $3,891
2015 $3,872
2014 $3,923
2013 $4,209
2012 $3,734
2011 $3,924
2010 $3,643
2009 $3,839
Teleflex Quarterly Total Assets
(Millions of US $)
2022-09-30 $6,758
2022-06-30 $6,732
2022-03-31 $6,873
2021-12-31 $6,872
2021-09-30 $7,040
2021-06-30 $7,066
2021-03-31 $7,028
2020-12-31 $7,153
2020-09-30 $6,613
2020-06-30 $6,765
2020-03-31 $6,702
2019-12-31 $6,310
2019-09-30 $6,257
2019-06-30 $6,314
2019-03-31 $6,268
2018-12-31 $6,278
2018-09-30 $6,201
2018-06-30 $6,175
2018-03-31 $6,301
2017-12-31 $6,181
2017-09-30 $5,681
2017-06-30 $5,290
2017-03-31 $5,232
2016-12-31 $3,891
2016-09-30 $4,002
2016-06-30 $4,000
2016-03-31 $3,943
2015-12-31 $3,872
2015-09-30 $3,908
2015-06-30 $3,984
2015-03-31 $3,924
2014-12-31 $3,923
2014-09-30 $4,058
2014-06-30 $4,064
2014-03-31 $4,242
2013-12-31 $4,209
2013-09-30 $3,788
2013-06-30 $3,724
2013-03-31 $3,694
2012-12-31 $3,734
2012-09-30 $3,671
2012-06-30 $3,607
2012-03-31 $3,650
2011-12-31 $3,924
2011-09-30 $3,869
2011-06-30 $3,878
2011-03-31 $3,679
2010-12-31 $3,643
2010-09-30 $3,798
2010-06-30 $3,744
2010-03-31 $3,774
2009-12-31 $3,839
2009-09-30 $3,808
2009-06-30 $3,779
2009-03-31 $3,806
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $10.587B $2.810B
Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.645B 22.45
Edwards Lifesciences (EW) United States $46.932B 32.30
Alcon (ALC) Switzerland $33.321B 28.69
STERIS (STE) Ireland $18.019B 22.42
Fresenius Medical Care AG KGaA (FMS) Germany $8.996B 9.03
Penumbra (PEN) United States $7.452B 1783.82
Globus Medical (GMED) United States $7.103B 36.11
Integer Holdings (ITGR) United States $2.367B 19.00
Glaukos (GKOS) United States $2.263B 0.00
Nevro (NVRO) United States $1.556B 0.00
Paragon 28 (FNA) United States $1.534B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.246B 17.74
Artivion (AORT) United States $0.520B 0.00